Cannabidiol Oral Solution
( DrugBank: Cannabidiol / KEGG DRUG: Cannabidiol )
4 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 140 | Dorabe syndrome | 2 |
| 144 | Lennox-Gastaut syndrome | 3 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 145 | West syndrome | 2 |
| 193 | Prader-Willi syndrome | 6 |
140. Dorabe syndrome
Clinical trials : 145 / Drugs : 74 - (DrugBank : 16) / Drug target genes : 52 - Drug target pathways : 68
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
144. Lennox-Gastaut syndrome
Clinical trials : 130 / Drugs : 79 - (DrugBank : 14) / Drug target genes : 51 - Drug target pathways : 64
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
145. West syndrome
Clinical trials : 52 / Drugs : 64 - (DrugBank : 19) / Drug target genes : 42 - Drug target pathways : 48
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
193. Prader-Willi syndrome
Clinical trials : 140 / Drugs : 137 - (DrugBank : 26) / Drug target genes : 51 - Drug target pathways : 64
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|